Motley Fool Small-Cap Growth ETF (BATS: TMFS)

Dernières nouvelles pour Motley Fool Small-Cap Growth ETF (BATS:TMFS)

Technology

Industrials

Healthcare

Financial Services

Consumer Cyclical

Consumer Defensive

Energy

Real Estate

The Small-Cap Growth Fund is an actively-managed exchange-traded fund (ETF) and invests primarily in equity securities of small capitalization companies listed on a United States exchange and selected by Motley Fool Asset Management, LLC (the Adviser), the Small-Cap Growth Funds investment adviser. The Small-Cap Growth Fund pursues its investment objective by using a quality growth style. The Small-Cap Growth Fund invests in a focused portfolio of the common stocks of high-quality companies domiciled in the United States that are engaged in a broad range of industries.

Goosehead Insurance Inc

Alarm.com Holdings Inc

Globus Medical Inc

Rxo, Inc.

Leonardo DRS Inc

Axon Inc

Watsco Inc

Smartsheet Inc.

Inari Medical Inc

Toast, Inc.

Q2 Holdings Inc Common Stock Usd 0.0001

Stonex Group Inc.

Healthequity

Sitime Corp

Penumbra Inc

Gxo Logistics Inc

Microsoft Corp

Nvidia Corp.

Apple Inc

Amazon.Com Inc

Alphabet Holding Company Inc.

Meta Platforms, Inc.

Berkshire Hathaway, Inc.

Broadcom Inc

Tesla, Inc.

Walmart, Inc.

Live Oak Bancshares Inc Common Stock Usd 0

Frontdoor Inc

Liveramp Holdings Inc

Ufp Technologies Inc

Northern Oil And Gas Inc Common Stock Usd 0.001

Motley Fool Small-Cap Growth ETF

Macro Economic Events

News

Econ #s

Economics

INDA

India Consumer Price Index (YoY) For May 2.82% Vs. 3.00% Est.; 3.16% Prior

HC Wainwright &amp; Co. analyst Heiko Ihle maintains Westwater Resources (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/WWR#AMEX">WWR</a>) with a Buy and lowers the price target from $2.5 to $2.

Price Target

Analyst Ratings

HC Wainwright & Co. Maintains Buy on Westwater Resources, Lowers Price Target to $2

<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" width="900" height="600" src="https://contributor-assets.benzinga.com/wp-content/uploads/2025/06/12082317/Biogene-01-900x600-1.png" alt="" class="wp-image-14317" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2025/06/12082317/Biogene-01-900x600-1.png 900w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/06/12082317/Biogene-01-900x600-1-300x200.png 300w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/06/12082317/Biogene-01-900x600-1-768x512.png 768w" sizes="(max-width: 900px) 100vw, 900px" /></figure>
A squabble involving false advertising claims by a sinking Bloomage Biotech against highflying rival Giant Biogene has captivated China, with no end in sight
<h4 class="wp-block-heading">Key Takeaways:</h4>
<ul class="wp-block-list">
<li>Shares of Giant Biogene have plunged 30% in the month since it was accused of false advertising by rival Bloomage Biotech</li>
<li>Biogene's stock had more than doubled before the squabble on success of its collagen skincare products, making it vulnerable to an attack by its jealous rival</li>
</ul>
A fight between skincare brands owned by two of China's wealthiest women has mesmerized the country with saturation media coverage – and left one of the pair's formerly highflying stocks badly bruised.
In nearly a month since the skirmish began on May 17, shares of&nbsp;Giant Biogene Holding Co. Ltd.&nbsp;(2367.HK) have shed nearly 30% of their value, while&nbsp;Bloomage BioTechnology Corp. Ltd.&nbsp;(688363.SH), which initiated the dust-up, is up about 7%.&nbsp;
While the allegations have the potential to dent both companies' reputations, the selloff for Biogene's stock, in particular, seems overblown. In its latest annual results, Biogene reported its revenue soared 57.2% last year to 5.5 billion yuan ($765 million), fueling a 42.4% profit gain to 2 billion yuan. Bloomage is moving in the other direction, reporting its revenue fell 12% last year to 5.37 billion yuan, as its profit plunged 71% to 174 million yuan.
So, how did this squabble between rising beauty Biogene and a fading Bloomage begin?&nbsp;
The two are known for different core products. Bloomage's use hyaluronic acid (HA), which helps the skin retain moisture. Biogene uses recombinant collagen, which helps new cells grow in the skin layer. Recombinant collagen has become all the rage lately, fueling Biogene's rapid rise and prompting Bloomage to invest in that area as well.
The fight may also have a personal element, either real or perceived, with much of the media attention focused on presumed tension between Biogene founder Fan Daidi and Bloomage founder Zhao Yan, two of China's wealthiest women.
Fan, a biochemist and former visiting scholar at MIT, founded Biogene in 2000 and built it into an industry-leading brand in 2024, according to Euromonitor. Its star product, "Comfy Collagen Stick" ranked first in sales on e-commerce platforms in China during the June 18 shopping festival last year.
Zhao started out as a banker, launching Bloomage in 2001 with an initial focus on the raw materials market for HA. In 2017 her company acquired Revitacare, a French maker of HA compounds. Bloomage then launched Biohyalux, a heavily discounted skincare brand, and has 44% of the global market for HA raw materials.
Bloomage fired the first shot in the battle by publishing a 5,000-word report on its official WeChat account accusing nine equity research houses of playing up the merits of recombinant collagen over HA. "The HA industry has encountered lies and trampling, and has been described as ‘outdated,' ‘not as safe as a certain substance,' ‘not as biologically active as a certain substance,' ‘not as market-valuable as a certain substance,'" the report said, in a thinly veiled reference to recombinant collagen.
A media field-day ensued, with some reports likening Zhao to a Chinese empress taking aim at imperial powers from the West.
The battle heated up 10 days later when beauty influencer Hao Yu, better known as "Dr. Big Mouth," who made headlines after previously accusing an Estee Lauder product of false advertising and discrimination against Chinese, took aim at Biogene. In his attack, Hao claimed the company had violated China's cosmetic labeling regulations after he found only trace levels of recombinant collagen in a Comfy product he tested.
<h4 class="wp-block-heading">Quick rebuttal</h4>
The Comfy brand quickly released a statement saying that it had immediately conducted tests showing more than 0.1% collagen content, well above Hao's finding of just 0.0177%. Biogene also commissioned third party testing agents to conduct independent tests.
Bloomage admitted days later that Hao was effectively on its payroll through an investment relationship.
But that didn't end the fight. On June 4, Comfy shared the test results on its website, saying it had not made any "false or misleading" claims for its product. One of the testing agencies cited by Hao also accused him of using its test results without permission and issued a letter of apology cited by Biogene.
That didn't stop Hao from continuing the fight, accusing Biogene a day later of pressuring testing institutions not to test the company's recombinant collagen products. He added that he had received a message from one such major company refusing to conduct a test because it didn't want to get caught up in the slugfest.
There are plenty of signs that financial pressure on Bloomage may have been partly behind its attacks against its up-and-coming rival. Bloomage previously delayed publication of its full-year results for 2024, publishing them just two weeks before its first-quarter results. Its first-quarter financials were also weak, showing the company's revenue fell 20.7% year-on-year to 1 billion yuan.
In addition to weak financials, Bloomage is also being plagued by other issues, including executive departures, changes to its management team and an internal anti-corruption campaign.
Revenue from Bloomage's skincare products declined by 32% in 2024 to 2.57 billion yuan, accounting for 48% of total revenue. According to Wind data, the company's market value peaked at 140 billion yuan in 2021, and has shriveled since then to a current 26 billion yuan. In December 2024, it was removed from the CSI 300 Index for China's most important publicly traded companies.
Meanwhile, Giant Biogene has moved in the opposite direction. Its revenue and net income both doubled between 2022 and 2024, and the company raised $80 million in its 2022 Hong Kong IPO. Since then, its stock has more than doubled from its IPO price of HK$24.30 to its latest close of HK$60.60 on Wednesday, giving the company a market cap of about HK$61 billion ($7.8 billion). The company is in a market that will growth by an average 55% annually between 2022 and 2027 to reach 64.5 billion yuan, according to independent research.
Biogene is hardly the only Chinese company benefitting from recent positive publicity for recombinant collagen skincare products. Other beneficiaries include&nbsp;Jinbo Bio-Pharmaceutical,&nbsp;Guangdong Marubi Biotechnology&nbsp;(603983.SS), and&nbsp;FREDA&nbsp;(600223.SS). But as the Biogene-Bloomage dust-up shows, highflying companies – and their investors – often make easy targets for jealous rivals.

Asia

Biotech

Global

Opinion

Giant Biogene Bruised In A 'Battle Of The Skincare Belles'

Keybanc analyst David Tarantino initiates coverage on Modine Manufacturing (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MOD#NYSE">MOD</a>) with a Overweight rating and announces Price Target of $125.

Initiation

Keybanc Initiates Coverage On Modine Manufacturing with Overweight Rating, Announces Price Target of $125

HC Wainwright &amp; Co. analyst Kevin Dede reiterates Digi Power X (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DGXX#NASDAQ">DGXX</a>) with a Buy and maintains $2.5 price target.

Reiteration

DGXX

HC Wainwright & Co. Reiterates Buy on Digi Power X, Maintains $2.5 Price Target

Wallbox (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WBX#NYSE">WBX</a>), a global leader in electric vehicle (EV) charging and energy management solutions, today announced the expansion of its partnership with ENSOL EV, the e-mobility division of Texas-based Ensol Energy Solutions LLC. This next phase of the collaboration includes the deployment of Wallbox's Supernova DC fast chargers across key urban centers and transit corridors locations in Texas, Florida, and Georgia, three states experiencing rapid growth in EV adoption and charging demand.
Initial installations are scheduled to begin in the second half of 2025, with additional sites to follow through early 2026. The Supernova fast charger delivers up to 180 kW of power and includes integrated smart charging features for optimal energy distribution and uptime performance.
 &nbsp;

Wallbox Expands Partnership With ENSOL EV To Deliver Fast Charging Infrastructure In Texas, Florida, And Georgia

ADC Therapeutics SA (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ADCT#NYSE">ADCT</a>), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced that it has entered into securities purchase agreements for the sale of its equity securities to certain institutional investors in a $100.0 million private investment in public equity ("PIPE") financing. In the PIPE, ADC Therapeutics is selling 13.0 million common shares at $3.53 per share and pre-funded warrants to purchase 15.7 million common shares at $3.43, per pre-funded warrant, which is the price per common share in the PIPE minus the exercise price of CHF 0.08 per pre-funded warrant.
&nbsp;
Gross proceeds from the PIPE financing are anticipated to be approximately $100.0 million before deducting placement agent fees and offering expenses. The PIPE is expected to close on June 16, 2025, subject to customary closing conditions. ADC Therapeutics intends to use the net proceeds from the PIPE to fund multiple catalysts primarily in support of ZYNLONTA&#xAE;&nbsp;clinical development as well as ZYNLONTA commercialization activities, working capital and general corporate purposes.

Offerings

ADCT

ADC Therapeutics Raises $100M in Private Stock Deal of 13M Shares at $3.5/Share And Warrants To Purchase 15.7M Shares At $3.43/Pre-funded Warrant to Boost Cancer Drug Development

WestPark Capital analyst Curtis Shauger maintains Oracle (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORCL#NYSE">ORCL</a>) with a Buy and raises the price target from $195 to $246.

ORCL

WestPark Capital Maintains Buy on Oracle, Raises Price Target to $246

On Wednesday, June 11, U.S. markets ended lower. The S&amp;P 500 slipped as investors grew wary over Middle East tensions and a reported embassy evacuation. A mild inflation report eased fears about tariff-driven price hikes, boosting hopes for future rate cuts.
Despite a tentative U.S.-China trade deal, skepticism lingered. Most sectors ended lower, with Amazon and Nvidia weighing heavily on the market.
According to economic data, the Bureau of Labor Statistics reported annual inflation at 2.4% in May, with core inflation steady at 2.8%, both slightly below expectations.
Most S&amp;P 500 sectors ended lower Wednesday, led by losses in materials, communication services, and consumer discretionary, while energy and utilities closed higher.
The Dow closed almost flat at 42,865.77, the S&amp;P 500 declined 0.27% to 6,022.24, and the Nasdaq slid 0.50% to 19,615.88.
<h2 class="wp-block-heading">Asia Markets Today</h2>
On Thursday, Japan&#8217;s Nikkei 225 closed 0.68% lower at 38,161.00, led by losses in the Paper &amp; Pulp, Transport and Communication sectors.
Australia&#8217;s S&amp;P/ASX 200 was down 0.31% at 8,565.10, led by losses in the Materials, Metals &amp; Mining and Resources sectors.
India&#8217;s Nifty 50 was down 1.06% at 24,871.70, and the Nifty 500 slid 1.29% to 23,036.05.
China&#8217;s Shanghai Composite was up 0.01% at 3,402.66, and Shanghai Shenzhen CSI 300 fell 0.06% to 3,892.20.
Hong Kong&#8217;s Hang Seng closed the session 1.36% lower at 24,035.38.
<h2 class="wp-block-heading">Eurozone at 05:45 AM ET</h2>
The European STOXX 50 index was down 0.91%.
Germany&#8217;s DAX index declined 1.23%.
France&#8217;s CAC 40 fell 0.61%.
U.K.&#8217;s FTSE 100 index traded lower by 0.16%.
<h2 class="wp-block-heading">Commodities at 05:45 AM ET</h2>
Crude Oil WTI was trading lower by 1.35% at $67.24/bbl, and Brent was down 1.35% at $67.47/bbl.
Oil prices fell as traders weighed rising Middle East tensions and a planned U.S.-Iran meeting following a sharp rally on supply disruption fears.
Natural gas rose 2.54% to $3.595.
Gold traded higher by 1.27% to $3,385.72, Silver slid 0.57% to $36.005, and Copper fell 0.37% to $4.7965.
Gold surged as safe-haven demand rose on Middle East tensions and tariff fears, while a weak dollar and uncertainty over U.S.-China trade talks boosted broader metal prices.
<h2 class="wp-block-heading">U.S. Futures</h2>
As of 5:45 AM ET, the Dow Jones futures were down 0.57%, the S&amp;P 500 declined 0.38%, and the Nasdaq 100 was down 0.31%.
<h2 class="wp-block-heading">Forex</h2>
As of 5:45 AM ET, the U.S. Dollar Index declined 0.71% to 97.96, USD/JPY was down 0.64% to 143.61, and USD/AUD slid 0.01% to 1.5381.
The dollar neared a 2025 low, and global stocks slipped as rising Middle East tensions and trade uncertainty pushed investors toward safe havens like gold, the yen, and the franc.
Photo via Shutterstock

Emerging Markets

Eurozone

Futures

Commodities

Forex

Markets

ADIV

AGOV

ASHR

BBEU

BOIL

CQQQ

PowerShares DBmmodity Index Optimum Yield Diversified Fund

EEMA

FLAX

CurrencyShares British Pound Sterling Trust

IEMG

IEUR

KraneShares Trust KraneShares S&P Pan Asia Dividend Aristocrats Index ETF

KDIV

SPEM

USDU

PowerShares DB US Dollar Index Bullish Fund

Asia And Europe Markets Slide, Dollar Softens On Inflation Data And Geopolitical Worries - Global Markets Today While US Slept

Needham analyst Ami Fadia reiterates Praxis Precision Medicine (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRAX#NASDAQ">PRAX</a>) with a Buy and maintains $80 price target.

PRAX

Needham Reiterates Buy on Praxis Precision Medicine, Maintains $80 Price Target

Acquisition would offer TELUS Digital shareholders liquidity at a compelling value and enhance TELUS Digital's ability to effectively respond to changing market dynamicsCloser operational integration between TELUS and
<ul>
<li>Acquisition would offer TELUS Digital shareholders liquidity at a compelling value and enhance TELUS Digital's ability to effectively respond to changing market dynamics</li>
<li>Closer operational integration between TELUS and TELUS Digital to supercharge AI and SaaS transformation across telecommunications, health, agriculture and consumer goods sectors</li>
<li>TELUS Digital to continue as a key enabler to TELUS' growth strategy and operational efficiency</li>
</ul>

TIXT

TELUS Proposes Full Acquisition of TELUS Digital To Accelerate AI And SaaS Transformation Across Core Business Sectors

<ul>
<li>MOBILIZE-1 is the first Phase 3 study being initiated for V181 as part of a planned robust clinical development program</li>
<li>Study will evaluate a single dose of V181 for the prevention of dengue disease caused by any of the four serotypes of the dengue virus regardless of previous exposure</li>
</ul>

Large Cap

Health Care

General

Merck Has Initiated MOBILIZE-1 Phase 3 Trial For Single Dose Of V181, An Investigational Quadrivalent Vaccine, For The Prevention Of Dengue Disease Caused By Any Of The Four Dengue Virus Serotypes. Recruitment For The Trial Has Begun, And The First Participants Are Now Enrolling In Singapore

Needham analyst Bernie McTernan reiterates Chewy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHWY#NYSE">CHWY</a>) from Hold to Hold.

CHWY

Needham Reiterates Hold on Chewyto Hold

CNX Resources Promotes Alan Shepard To President In Addition To His Current Role As CFO

The Trump administration has unveiled a new trade deal framework with China, but experts remain doubtful about its long-term viability and warn that the U.S. may be giving up its strategic advantage in the agreement.
What Happened: The deal aims to de-escalate tensions between the two nations, with both sides agreeing to roll back actions taken since the initial deal was struck on May 12. However, the deal is still pending approval from President Donald Trump and Chinese President Xi Jinping, <a href="https://www.politico.com/news/2025/06/11/trump-announced-another-deal-with-china-will-it-hold-00400288">reported</a> Politico.
Notably, the U.S. has agreed to further concessions, including easing restrictions on the export of certain sensitive products to China and resuming the issuance of student visas for Chinese nationals. In contrast, China has merely reiterated its earlier promise—made a month ago—to lift the blockade on critical mineral shipments. Despite the progress, experts are cautious. Derek Scissors, a senior fellow at the American Enterprise Institute, said, "This is another band aid.&#8221; He warns that China could easily reinstate the blockade on rare earths, a move that could severely impact global supply chains.
Former&nbsp;deputy assistant U.S. Trade Representative&nbsp;Emily Kilcrease&nbsp;believes the deal sets a &#8220;very dangerous precedent&#8221; by potentially weakening U.S. export controls.&nbsp;
Meanwhile, Marc Busch,&nbsp;a professor of international business&nbsp;diplomacy at Georgetown University, adds that China&#8217;s rhetoric remains unchanged, casting doubt on the sustainability of the trade truce. "China has always had this trump card, they know how to use it..,&#8221; cautioned Busch.
SEE ALSO:&nbsp;<a href="https://benzinga.com/crypto/25/06/45896615/us-recession-odds-tumble-to-23-on-crypto-betting-market-after-trump-confirms-china-trade-deal-softer-infla" target="_blank" rel="noreferrer noopener">US Recession Odds Tumble To 23% On Crypto Betting Market After Trump Confirms China Trade Deal, Softer Inflation Numbers</a>
Why It Matters: The recent deal follows the implementation of the Geneva trade consensus, which resulted in a 90-day pause on tariffs imposed on China. This agreement was reached <a href="https://www.benzinga.com/news/macro-notification/25/06/45876366/howard-lutnick-says-us-and-china-reached-a-framework-to-implement-geneva-consensus-following-trump-xi-call-csi-300-index-gains">after two days</a> of high-level discussions in London.
Meanwhile, Treasury Secretary&nbsp;Scott Bessent&nbsp;has suggested that the Trump administration may consider extending the current 90-day tariff pause beyond July 9 for the U.S.&#8217;s top trading partners. This extension, however, is <a href="https://www.benzinga.com/markets/macro-economic-events/25/06/45898040/scott-bessent-signals-willingness-to-extend-tariff-pause-for-good-faith-negotiations-trump-thinks-not-a-necessity">contingent </a>on the partners&#8217; &#8220;good faith&#8221; in ongoing trade negotiations.
These developments indicate a potential shift in the U.S.-China trade dynamic, with ongoing negotiations and agreements potentially shaping future trade relations.
<ul class="wp-block-list">
<li>READ MORE:&nbsp;<a href="https://benzinga.com/crypto/cryptocurrency/25/06/45891099/fartcoin-surges-40-in-a-week-on-coinbase-listing-outshines-dogecoin-shiba-inu" target="_blank" rel="noreferrer noopener">Fartcoin Surges 40% In A Week On Coinbase Listing, Outshines Dogecoin, Shiba Inu &#8211; Benzinga</a></li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

'This Is Another Band-Aid,' Say Experts, Questioning Long-Term Viability And Efficacy Of US-China Trade Deal: 'China Always Had This Trump Card'

U.S. Marines will deploy to Los Angeles streets within 48 hours with authority to detain civilians, escalating federal-state tensions as California sues to block military involvement in immigration enforcement.
What Happened: President Donald Trump ordered Marines to deploy on Los Angeles streets amid ongoing protests against immigration raids, despite objections from California Governor Gavin Newsom, reported Reuters. The deployment marks the first <a href="https://www.benzinga.com/news/politics/25/06/45830221/gavin-newsom-calls-deployment-of-national-guard-in-los-angeles-unlawful-says-there-was-no-problem-until-trump-got-involved-serious-breach-of-state-sovereignty">federal activation of National Guard </a>without gubernatorial consent since 1965.
The Marines concluded specialized training, including de-escalation and crowd control techniques. Under Title 10 authority, they can temporarily detain individuals interfering with Immigration and Customs Enforcement operations or assaulting federal officers, according to Northern Command.
Army Major General Scott Sherman confirmed Marines will not carry live ammunition in rifles, but will carry live rounds.
The protests erupted in response to a series of immigration raids. ICE operations <a href="https://www.benzinga.com/markets/equities/25/06/45854643/home-depot-targeted-in-immigration-raids-amid-la-protests-threatening-customer-traffic">targeted multiple locations, </a>including The Home Depot Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HD#NYSE">HD</a>) stores in Westlake, Whittier, and Huntington Park.
See Also: <a href="https://www.benzinga.com/markets/tech/25/06/45898547/openai-looks-to-raise-40-billion-from-global-investors-including-saudi-arabias-pif-indias-reliance-industries-to-accelerate-ai-models-and-stargate-report">OpenAI Looks To Raise $40 Billion From Global Investors Including Saudi Arabia&#8217;s PIF, India&#8217;s Reliance Industries To Accelerate AI Models And Stargate: Report</a>
Why It Matters: California filed suit Tuesday seeking a temporary restraining order, with hearings scheduled Thursday in San Francisco federal court.
California Attorney General Rob Bonta warned the federal troop deployment could violate the 1878 Posse Comitatus Act restricting military involvement in civilian law enforcement. The Trump administration contends the president has discretion to determine when &#8220;rebellion or danger of rebellion&#8221; requires a military response. Demonstrations spread nationwide to New York, Atlanta, Chicago, and other major cities. ICE operations averaged 2,000 daily arrests, significantly exceeding the 311 daily average under former President Biden. The escalation occurs as activists plan over 1,800 anti-Trump demonstrations Saturday coinciding with Trump&#8217;s 79th birthday. Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/06/45898644/tim-cook-explains-why-apples-f1-movie-bet-with-lewis-hamilton-serve-more-than-just-iphone-sales">Tim Cook Explains Why Apple&#8217;s &#8216;F1&#8217; Movie Bet With Lewis Hamilton Serves More Than Just iPhone Sales</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo courtesy: Joey Sussman / Shutterstock.com

Politics

TSLA

Trump Deploys Marines To LA With Authority to Detain Civilians: California Challenges Military Involvement In Immigration Enforcement

Alert confirms uptrend early in the session on a down day for the broad market
<figure class="wp-block-image size-large"><img decoding="async" src="https://contributor-assets.benzinga.com/wp-content/uploads/2025/06/11194731/Screenshot-2025-06-11-at-3.46.28%E2%80%AFPM-1024x881.png" alt="" class="wp-image-14300" /></figure>
McDonald&#8217;s Corp. (MCD) today experienced a Power Inflow, a significant event for those who follow where smart money goes and value order flow analytics in their trading decisions. 
Today, at 10:28 AM on June 11th, a significant trading signal occurred for McDonald&#8217;s Corp., (MCD) as it demonstrated a Power Inflow at a price of $300.12. This indicator is crucial for traders who want to know directionally where institutions and so-called "smart money" moves in the market. They see the value of utilizing order flow analytics to guide their trading decisions. The Power Inflow points to a possible uptrend in McDonald's stock, marking a potential entry point for traders looking to capitalize on the expected upward movement. Traders with this signal closely watch for sustained momentum in McDonald&#8217;s stock price, interpreting this event as a bullish sign.
Signal description
Order flow analytics, aka transaction or market flow analysis, separate and study both the retail and institutional volume rate of orders (flow). It involves analyzing the flow of buy and sell orders, along with size, timing, and other associated characteristics and patterns, to gain insights and make more informed trading decisions. This particular indicator is interpreted as a bullish signal by active traders.&nbsp;
The Power Inflow occurs within the first two hours of the market open and generally signals the trend that helps gauge the stock's overall direction, powered by institutional activity in the stock, for the remainder of the day.&nbsp;
By incorporating order flow analytics into their trading strategies, market participants can better interpret market conditions, identify trading opportunities, and potentially improve their trading performance. But let's not forget that while watching smart money flow can provide valuable insights, it is crucial to incorporate effective risk management strategies to protect capital and mitigate potential losses. Employing a consistent and effective risk management plan helps traders navigate the uncertainties of the market in a more controlled and calculated manner, increasing the likelihood of long-term success
If you want to stay updated on the latest options trades for MCD, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts. 
<a href="https://benzinga.com/apis?_gl=1&#x2A;1hlgn5i&#x2A;_ga&#x2A;MTY1NjE2NTYxMi4xNzE0NzQ4MTAy&#x2A;_ga_V7ZK73W7N0&#x2A;MTcxNDc0ODEwMi4xLjEuMTcxNDc0ODQyOC4wLjAuMA..">Market News and Data brought to you by Benzinga APIs</a> and include firms, like <a href="https://tradepulse.net/?utm_source=Benzinga&amp;utm_medium=Article&amp;utm_campaign=brand_awareness_June2025">https://tradepulse.net/?utm_source=Benzinga&amp;utm_medium=Article&amp;utm_campaign=brand_awareness_June2025</a>, which are responsible for parts of the data within this article.
After Market Close UPDATE:
The price at the time of the Power Inflow was $300.12. The returns on the High price ($303.20) and Close price ($301.72) after the Power Inflow are respectively 1.0% and 0.5%. The result underlines the importance of a trading plan that includes Profit Targets and Stop Losses that reflect your risk appetite.
Past performance is not indicative of future results

Equities

Technicals

Signals

Trading Ideas

McDonald's Stock Rises 1% After Key Trading Signal

Editor&#8217;s Note: The story has been updated to include Boeing's comments.
An Air India Boeing 787-8 Dreamliner by&nbsp;Boeing Co.&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>) crashed on Thursday near the Ahmedabad airport, with 242 passengers on board. The flight was en route to London Gatwick from Ahmedabad.
What Happened:&nbsp;The Air India flight, AI171, met with a tragic fate during takeoff from the Sardar Vallabhbhai Patel International Airport in Ahmedabad on Thursday.
The passenger aircraft, a Boeing 787 Dreamliner with a capacity of 300, crashed in the Meghani area of the city. Thick smoke was seen rising from Dharpur near Meghaninagar, suggesting a major fire likely caused by the substantial fuel load carried for the long-haul flight to London. Emergency response units and fire brigade teams have been deployed to the scene.
Boeing tells Benzinga, &#8220;We are aware of initial reports and are working to gather more information.&#8221;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Flight AI171, operating Ahmedabad-London Gatwick, was involved in an incident today, 12 June 2025. At this moment, we are ascertaining the details and will share further updates at the earliest on <a href="https://t.co/Fnw0ywg2Zt">https://t.co/Fnw0ywg2Zt</a> and on our X handle (<a href="https://t.co/Id1XFe9SfL">https://t.co/Id1XFe9SfL</a>). -Air India…
&mdash; Air India (@airindia) <a href="https://twitter.com/airindia/status/1933086483142902226?ref_src=twsrc%5Etfw">June 12, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
SEE ALSO:&nbsp;<a href="https://benzinga.com/crypto/cryptocurrency/25/06/45898426/michael-saylor-shrugs-off-quantum-computing-threat-to-bitcoin-warns-companies-like-microsoft-google-more-vulnerable-youll-see-it-coming-a-mile-away" target="_blank" rel="noreferrer noopener">Michael Saylor Shrugs Off Quantum Computing Threat To Bitcoin, Warns Companies Like Microsoft, Google More Vulnerable: &#8216;You&#8217;ll See It Coming A Mile Away&#8217; </a>
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">We are following reports of a crash of Air India flight <a href="https://twitter.com/hashtag/AI171?src=hash&amp;ref_src=twsrc%5Etfw">#AI171</a> from Ahmedabad to London. We received the last signal from the aircraft at 08:08:51 UTC, just seconds after take off. The aircraft involved is a Boeing 787-8 Dreamliner with registration VT-ANB… <a href="https://t.co/EmKKISJldF">pic.twitter.com/EmKKISJldF</a>
&mdash; Flightradar24 (@flightradar24) <a href="https://twitter.com/flightradar24/status/1933086087682904336?ref_src=twsrc%5Etfw">June 12, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Why It Matters: This incident adds to the recent challenges faced by Boeing. In 2024, a Boeing 737-800 operated by South Korea's <a href="https://www.benzinga.com/markets/equities/24/12/42716905/boeing-in-spotlight-after-fatal-737-800-crash-in-south-korea-stock-declined-28-amid-deepening-2024-challenges">JejuAir crashed</a>, killing 179 of 181 passengers. This raised serious questions about Boeing&#8217;s safety record and led to a 30% stock decline in the same year.
In May, the U.S. Department of Justice (DoJ) moved to dismiss a <a href="https://www.benzinga.com/markets/equities/25/05/45689735/us-justice-department-seeks-to-dismiss-boeings-fraud-charges-on-737-max-crashes-that-killed-over-300">criminal fraud</a> charge against Boeing, linked to two fatal 737 MAX plane crashes that claimed 346 lives. This decision followed an agreement between Boeing and the Justice Department.
In January 2013, the entire global fleet of Boeing 787 Dreamliners was grounded following a series of safety incidents linked to the aircraft&#8217;s lithium-ion batteries. The U.S. Federal Aviation Administration (FAA) responded by issuing an emergency airworthiness directive, requiring airlines to prove the safety of the batteries before resuming operations. Aviation authorities in Europe, Japan, and other regions quickly followed suit, grounding all Dreamliners operated by eight airlines worldwide. Boeing, while standing by the integrity of the 787, worked with regulators and airlines to develop technical solutions, including redesigning the battery system and adding fireproof containment, before the aircraft was cleared to return to service about three months later
During Thursday&#8217;s pre-market trading session, shares of Boeing declined 7.2%. On a year-to-date basis, it surged 24.51%.
<ul class="wp-block-list">
<li>READ MORE:&nbsp;<a href="https://benzinga.com/analyst-stock-ratings/initiation/25/06/45881612/this-coinbase-global-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-wednesday" target="_blank" rel="noreferrer noopener">This Coinbase Global Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday</a></li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Boeing Dreamliner Carrying Over 200 Passengers Crashes Shortly After Takeoff Near India's Ahmedabad: BA Stock Falls Over 7% In Thursday Pre-Market (UPDATED)

Something's shifting in the bond market, with a new wave of unease creeping in, and some of Wall Street's most experienced voices observing a sombre silence.
What Happened: On Wednesday, Spencer Hakimian, the founder of Tolou Capital Management, shared a post on X highlighting a growing consensus among the world&#8217;s leading fixed income traders that U.S. Treasuries are no longer the safe bet that they once were.
According to the screenshot of the Bloomberg article shared by Hakimian, large fixed income operators, such as DoubleLine Capital, Pacific Investment Management Co. (PIMCO), and TCW Group, are all backing away from long-dated U.S. government bonds. 
See Also: <a href="https://www.benzinga.com/news/politics/25/06/45898797/trump-and-jd-vance-push-fed-to-slash-interest-rates-after-mild-inflation-report-calling-current-policy-monetary-malpractice">Trump And JD Vance Push Fed To Slash Interest Rates After Mild Inflation Report, Calling Current Policy &#8216;Monetary Malpractice&#8217;</a>
They're instead opting for shorter-term Treasuries, citing escalating federal debt and interest-rate risks, highlighting deepening anxiety in the U.S. fiscal trajectory. 
While sharing the screenshot, Hakimian writes, &#8220;The best bond traders in the world telling you straight up to stop buying bonds,&#8221; adding that it&#8217;s because &#8220;our country is bankrupt,&#8221; and no one is bold enough to fix it.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">The best bond traders in the world telling you straight up to stop buying bonds because our country is bankrupt and no one has the balls to fix it. <a href="https://t.co/ZbJLjWeKro">pic.twitter.com/ZbJLjWeKro</a>
&mdash; Spencer Hakimian (@SpencerHakimian) <a href="https://twitter.com/SpencerHakimian/status/1932928295407853790?ref_src=twsrc%5Etfw">June 11, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
In another post on X, just a few minutes before this one, Hakimian highlights the growing U.S. entitlement spending, which he says is going up 15% year-over-year. &#8220;No one cares,&#8221; he says, adding that neither party can implement a solution, as &#8220;we&#8217;re selling bonds into oblivion.&#8221;
&#8220;Our currency has lost all its value against real currencies like Gold and Bitcoin,&#8221; he says, while saying that the U.S. is headed right into the &#8220;graveyard of failed empires&#8221; because of this problem. Hakimian concludes by saying, &#8220;invest accordingly.&#8221; 
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Entitlement spending is literally going up +15% Y/Y. No one cares. Neither party can implement a solution. We're selling bonds into oblivion. Our currency has lost all its value against real currencies like Gold and Bitcoin. We're heading right towards the graveyard of… <a href="https://t.co/sUnTPHaAtK">pic.twitter.com/sUnTPHaAtK</a>
&mdash; Spencer Hakimian (@SpencerHakimian) <a href="https://twitter.com/SpencerHakimian/status/1932923531899134257?ref_src=twsrc%5Etfw">June 11, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Why It Matters: Several experts and economists have raised concerns regarding America&#8217;s fiscal trajectory, especially in-light of President Donald Trump&#8217;s &#8220;One Big, Beautiful Bill,&#8221; which is expected to make it worse.
Former Treasury Secretary Lawrence Summers recently called the <a href="https://www.benzinga.com/markets/25/05/45686699/larry-summers-issues-stark-warning-the-big-beautiful-bill-is-actually-a-prescription-for-deadly-dangerous-decline">bill a prescription for</a> &#8220;deadly, dangerous decline,&#8221; while calling it a setup for a potential &#8220;Liz Truss moment,&#8221; referring to the former British Prime Minister&#8217;s short reign, which was upended by turmoil in the bond market.
Even Trump-ally, Elon Musk, has come out in <a href="https://www.benzinga.com/news/25/05/45635854/elon-musk-disappointed-with-trumps-big-beautiful-bill-says-it-undermines-the-work-that-the-doge-team-is-doing">criticism of the bill</a>, saying that it "undermines the work" that the Department of Government Efficiency (DOGE) has been doing under his leadership.
Read More: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/06/45899175/general-motors-cfo-says-4-billion-investment-will-allow-company-to-rebalance-production-amid-trump-tariffs">General Motors CFO Says $4 Billion Investment Will Allow Company To Rebalance Production Amid Trump Tariffs</a></li>
</ul>
Photo courtesy: Shutterstock

Bonds

Wall Street Bond Giants Retreat From Long-Term Treasuries Amid 'Spiraling Federal Debt'

Needham analyst Ami Fadia reiterates Biogen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIIB#NASDAQ">BIIB</a>) from Hold to Hold.

BIIB

Needham Reiterates Hold on Biogento Hold

Comments

Motley Fool Small-Cap Growth ETF

Actualités

Dernières nouvelles pour Motley Fool Small-Cap Growth ETF (BATS:TMFS)

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL